What is the CRT0066101?

CRT0066101 is , while it's Molecular Formula is C 18 H 19 ClN 4 O. Used in Cancer Therapy: CRT0066101 is used as a therapeutic agent for inhibiting PDK1, which plays a critical role in cell growth and survival. This makes it a potential candidate for cancer therapy, as it may help in controlling abnormal cell growth and survival associated with cancer. Used in Overcoming Drug Resistance in Cancer Cells: CRT0066101 is used as a potential agent for overcoming drug resistance in cancer cells. Its ability to target PDK1 may help in enhancing the effectiveness of conventional cancer treatments and improving therapeutic outcomes in resistant cases. Used in Drug Development and Molecular Mechanism Research: CRT0066101 is used as a target for further investigation in drug development and the understanding of molecular mechanisms underlying cancer progression. Its potential applications in cancer therapy and overcoming drug resistance make it an important molecule for research and development of novel therapeutic strategies.

What is the CAS number for CRT0066101?

The CAS number of CRT0066101 is 956121-30-5.

What is CRT0066101 (956121-30-5) used for?

CRT0066101 is a small molecule inhibitor that has been studied for its potential therapeutic effects. It has been shown to inhibit PDK1, a protein kinase that plays a critical role in cell growth and survival. By targeting PDK1, CRT0066101 may have potential applications in cancer therapy, as well as in the treatment of other diseases that are driven by abnormal cell growth.

What is the CRT0066101?

CRT0066101 is , while it's Molecular Formula is C 18 H 19 ClN 4 O. Used in Cancer Therapy: CRT0066101 is used as a therapeutic agent for inhibiting PDK1, which plays a critical role in cell growth and survival. This makes it a potential candidate for cancer therapy, as it may help in controlling abnormal cell growth and survival associated with cancer. Used in Overcoming Drug Resistance in Cancer Cells: CRT0066101 is used as a potential agent for overcoming drug resistance in cancer cells. Its ability to target PDK1 may help in enhancing the effectiveness of conventional cancer treatments and improving therapeutic outcomes in resistant cases. Used in Drug Development and Molecular Mechanism Research: CRT0066101 is used as a target for further investigation in drug development and the understanding of molecular mechanisms underlying cancer progression. Its potential applications in cancer therapy and overcoming drug resistance make it an important molecule for research and development of novel therapeutic strategies.

What is the CAS number for CRT0066101?

The CAS number of CRT0066101 is 956121-30-5.

What is CRT0066101 (956121-30-5) used for?

CRT0066101 is a small molecule inhibitor that has been studied for its potential therapeutic effects. It has been shown to inhibit PDK1, a protein kinase that plays a critical role in cell growth and survival. By targeting PDK1, CRT0066101 may have potential applications in cancer therapy, as well as in the treatment of other diseases that are driven by abnormal cell growth.

Products

Product classification

Contact us

Tel：+86-0533-2185556
Fax：+86-0533-2185556
Phone：WhatsApp: +86 15965530500
Website：https://www.shandonghangyubiotech.com
Email：admin@hangyubiotech.com
Address：Room 2516, Dingcheng Building, Beijing Road, Zhangdian District, Zibo City, Shandong Province

956121-30-5

Product Name:CRT0066101
Molecular Weight:342.828

Inquiry

Product Details

Purity:99%

CRT0066101 GMP Manufacturer Global Trade 956121-30-5 with Fast Delivery

Molecular Formula:C₁₈H₁₉ClN₄O
Molecular Weight:342.828
Boiling Point:480.0±45.0 °C(Predicted)
PKA:8.00±0.48(Predicted)
Density:1.325±0.06 g/cm3(Predicted)

956121-30-5 Relevant articles

AMINO-ETHYL-AMINO-ARYL (AEAA) COMPOUNDS AND THEIR USE

-

Page/Page column 130, (2009/10/06)

The present invention pertains generally...

956121-30-5 Process route

: 956121-30-5
2-[4-((R)-2-aminobutylamino)quinazolin-2-yl]-4-chlorophenol

Conditions

Conditions	Yield

Relevant Products

RMC-7977，
CAS：2765082-12-8
Bevacizumab
CAS：216974-75-3
BMS453
CAS：166977-43-1
A 286982
CAS：280749-17-9

Home

About us

Products

small-molecule inhibitor

intermediate

Pharmaceutical intermediate

Biochemical reagent

fire retardant

chemical reagent

ionic liquid

Inhibitor

Antibody

Pesticide

New materials

Customization

Nucleosides

Food additives

Supplement

API

Pharmaceutical intermediates

Biological products

Polypeptides

Chemical reagents

Small molecule inhibitors

Organic electronic chemical materials

Technical Support

News

Contact Us